Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT00771056
Eligibility Criteria:
Inclusion Criteria:
* Flow cytometry confirmed B-CLL
* No prior chemotherapy or immunotherapy
* Performance status 0-2
* Age \> 18 years old
* If childbearing age, woman you must be willing to use birth control for length of hydroxychloroquine use
* Must have capacity to consent for study and sign consent form
* Asymptomatic CLL not requiring treatment at time of study entry
Exclusion Criteria:
* Pregnancy
* Significant optic nerve pathology as documented by an opthalmologic exam
* Hypersensitivity to 4-aminoquinoline compound
* Patients taking cardiac glycosides and cyclosporine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00771056
Study Brief:
Protocol Section:
NCT00771056